Trials / Recruiting
RecruitingNCT06228001
Holter of Movement in Patients With Amyotrophic Lateral Sclerosis.
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Liege · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
ActiALS is a multicentric academic study. Patients with amyotrophic lateral sclerosis (ALS) may be included on a voluntary basis. The investigators plan to include a group of approximately 30 patients with ALS. The investigators have planned to assess patient every three months for a year. After each visit, participants will wear Actimyo for one month daily.
Detailed description
On each visit, participants will undergo a clinical examination with MRC sum score and Ashworth scores. Participants will perform few tests (6-minutes walk test (6MWT), dynamometric measure, electromyography, and will answer to some questionaires (dysphagia handicap scale, Revised Amyotrophic Lateral Sclerosis Functional Rating Scale). Actimyo is an innovative device intended to be used in a home-based environment. It is composed of two watch-like sensors, each containing a magneto-inertial sensors that record the linear acceleration, the angular velocity, the magnetic field of the movement in all directions.The two watches can be worn as wristwatch or placed near the ankle.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Actimyo | Actimyo is an innovative device intended to be used in a home-based environment. It is composed of two watch-like sensors, each containing a magneto-inertial sensors that record the linear acceleration, the angular velocity, the magnetic field of the movement in all directions.The two watches can be worn as wristwatch or placed near the ankle. |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2028-01-01
- Completion
- 2028-01-01
- First posted
- 2024-01-29
- Last updated
- 2025-05-19
Locations
3 sites across 2 countries: Belgium, Egypt
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06228001. Inclusion in this directory is not an endorsement.